Enhanced Anti-Cancer Effect of Folate-Conjugated Olaparib Nanoparticles Combined with Radiotherapy in Cervical Carcinoma.

Dong LiChuanfei HuJuan YangYin LiaoYue ChenShao Zhi FuJing Bo Wu

Published in: International journal of nanomedicine (2020)

The ATO developed in this study may represent a novel formulation for olaparib delivery and have promising potential for treating tumors with an over-expression of folate receptors.

Keyphrases

poor prognosis
early stage
drug delivery
radiation therapy
locally advanced
squamous cell carcinoma
radiation induced
long non coding rna